Proposed MU Rules Draw Strong Reaction
American Medical Association (AMA) and 98 state and specialty medical societies:
The AMA sides with the AHA in terms of meeting a requirement for online access to patient health information. The 10% requirement "unfairly predicates the physician's success for meeting the measure on patient compliance and should be eliminated."
For Stage 2, CMS proposes that 50% of all unique patients seen by the physician be provided online access to their health information within four business days after the information is available to the physician. The AMA would like the threshold requirement to be 20% not 50%. AMA contends that the four-day timeframe is "inconsistent with the HIPAA."
It notes that for Stage 2, CMS proposes that the reporting period be the entire calendar year. "The sheer volume of patient information that has to be made available within four business days for the entire calendar year would be extraordinary for most practices and their staff to manage."
The AMA opposes back-dating of the MU penalty program, or for that matter, any other quality or health IT penalty program, including e-prescribing and PQRS. "If Congress intended that these penalty programs be back-dated, the legislation would have stated so. CMS is essentially pushing up deadlines for participation by a full year or more due largely to its own data processing limitations." The AMA asks CMS to allow physicians to successfully meet Stage 2 MU measures for 90 consecutive days during the first six months of 2015 to avoid the 2015 penalty. It says the process should be extended to 2016 and 2017.
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Top-Ranked MA Plans Earn Their Stars
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- Defensive Medicine Still Prevalent Despite Tort Reform
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening
- WellPoint Dominates Nearly Half of Markets, AMA Says